Michael York - Feb 18, 2022 Form 3 Insider Report for Metacrine, Inc. (MTCR)

Role
Chief Business Officer
Signature
/s/ Michael York
Stock symbol
MTCR
Transactions as of
Feb 18, 2022
Transactions value $
$0
Form type
3
Date filed
2/24/2022, 03:52 PM
Previous filing
May 24, 2021
Next filing
Mar 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MTCR Stock Option (right to buy) Feb 18, 2022 Common Stock 235K $1.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest one year after the Vesting Commencement Date of December 1, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter until fully vested on December 1, 2025.